BioCentury
ARTICLE | Clinical News

CCD 1042 synthetic Epalon anticonvulsant that mimics brain steroids: Began international Phase II trials for tolerability and anticonvulsant action in a broad r

January 9, 1995 8:00 AM UTC

CoCensys Inc. (COCN), Irvine, Calif. Product: CCD 1042 synthetic Epalon anticonvulsant that mimics brain steroids Indication: Epilepsy Status: Began international Phase II trials for tolerability and ...